Literature DB >> 18534229

A functional polymorphism in the tyrosine hydroxylase gene indicates a role of noradrenalinergic signaling in sudden infant death syndrome.

Michael Klintschar1, Barbara Reichenpfader, Klaus-Steffen Saternus.   

Abstract

OBJECTIVES: Catecholamines may contribute to the cause of sudden infant death syndrome (SIDS). TH01, a tetrameric short tandem repeat marker in the tyrosine hydroxylase gene, regulates gene expression and catecholamine production. STUDY
DESIGN: We investigated TH01 in 172 German Caucasian SIDS cases and 390 sex- and age-matched control subjects.
RESULTS: The *9.3 alleles were more frequent in patients with SIDS than in control subjects (40.12% vs 31.15%; P = .006). For homozygotes the odds ratio was 1.83 (95% confidence interval: 1.09-3.05), for carriers 1.58 (1.09-2.28). Moreover, *9.3 alleles were significantly more frequent during the winter (47.73% vs 35.38% in the warmer seasons), and the frequency of *9.3 alleles varied significantly with the age at death (weeks 7 to 12: 49.04% vs 29.63% within the first 6 weeks). Other risk factors (sleeping position, gestation, smoking) had no significant impact on the frequency of *9.3.
CONCLUSIONS: Our results indicate a relationship between SIDS and TH01 genotype, presumably caused by an impairment of breathing regulation or arousal. We propose that noradrenalinergic neuronal activity contributes to the cause of a major subset of SIDS victims. Moreover, the results further stress that SIDS is a highly heterogenic group.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18534229     DOI: 10.1016/j.jpeds.2008.02.032

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  13 in total

1.  Association of TH01 with human longevity revisited.

Authors:  Nicole von Wurmb-Schwark; Amke Caliebe; Thorsten Schwark; Rabea Kleindorp; Micaela Poetsch; Stefan Schreiber; Almut Nebel
Journal:  Eur J Hum Genet       Date:  2011-03-16       Impact factor: 4.246

Review 2.  Gene variants predisposing to SIDS: current knowledge.

Authors:  Siri H Opdal; Torleiv O Rognum
Journal:  Forensic Sci Med Pathol       Date:  2010-07-11       Impact factor: 2.007

3.  That's not it, either-neither polymorphisms in PHOX2B nor in MIF are involved in sudden infant death syndrome (SIDS).

Authors:  Micaela Poetsch; Rebecca Todt; Mechtild Vennemann; Thomas Bajanowski
Journal:  Int J Legal Med       Date:  2015-06-24       Impact factor: 2.686

4.  Association between polymorphisms in the P2RY1 and SSTR2 genes and sudden infant death syndrome.

Authors:  Katharina Läer; Marielle Vennemann; Thomas Rothämel; Michael Klintschar
Journal:  Int J Legal Med       Date:  2013-07-05       Impact factor: 2.686

5.  Polymorphisms in genes of respiratory control and sudden infant death syndrome.

Authors:  Katharina Läer; Thilo Dörk; Marielle Vennemann; Thomas Rothämel; Michael Klintschar
Journal:  Int J Legal Med       Date:  2015-07-22       Impact factor: 2.686

6.  Questionable association between a monoamine oxidase A promoter polymorphism and sudden infant death syndrome.

Authors:  Michael Klintschar; Christian Heimbold
Journal:  Neurogenetics       Date:  2010-04-01       Impact factor: 2.660

7.  Candidate gene variants of the immune system and sudden infant death syndrome.

Authors:  Delnaz Fard; Katharina Läer; Thomas Rothämel; Peter Schürmann; Matthias Arnold; Marta Cohen; Mechtild Vennemann; Heidi Pfeiffer; Thomas Bajanowski; Arne Pfeufer; Thilo Dörk; Michael Klintschar
Journal:  Int J Legal Med       Date:  2016-03-14       Impact factor: 2.686

8.  Sodium/proton exchanger 3 (NHE3) and sudden infant death syndrome (SIDS).

Authors:  Jacqueline Studer; Christine Bartsch; Cordula Haas
Journal:  Int J Legal Med       Date:  2014-03-04       Impact factor: 2.686

9.  Association between monoamine oxidase A promoter polymorphism and the risk of sudden infant death syndrome: a meta-analysis.

Authors:  Qiaoxia Zhou; Daoyin Gong; Yu Zhang; Feijun Huang
Journal:  Int J Legal Med       Date:  2021-02-01       Impact factor: 2.686

10.  Genomic risk factors in sudden infant death syndrome.

Authors:  David W Van Norstrand; Michael J Ackerman
Journal:  Genome Med       Date:  2010-11-30       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.